Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hetero Drugs Ltd.

http://www.heterodrugs.com

Latest From Hetero Drugs Ltd.

Patents And LOEs Poised To Be Hot Q2 Topics

Novartis and Johnson & Johnson will be the first two big pharmas to release second quarter financial results, and both have faced recent patent case developments for top-selling drugs.

Intellectual Property Business Strategies

Medicines Patent Pool Facilitates Deals With Seven Manufacturers For COVID-19 Antiviral

The Medicines Patent Pool has facilitated sublicenses with seven manufacturers to distribute generic versions of Shionogi’s oral COVID-19 antiviral ensitrelvir across low- and middle-income countries.

Coronavirus COVID-19 Intellectual Property

Shionogi's Xocova Extends Global Reach Through First MPP Sublicenses

The first sublicensing deals through MPP for Shionogi's oral COVID antiviral Xocova with seven firms in China, India, Ukraine and Vietnam suggest the global debut of generic versions will come earlier than usual after the original, which continues in multiple global Phase III programs in various settings. While sales hopes are high, the drug may also be hit by a price cut in its first and biggest market so far – Japan.

 

Commercial Coronavirus COVID-19

MPP Facilitates Agreements With Seven Manufacturers For COVID-19 Antiviral

The Medicines Patent Pool has facilitated sublicenses with seven manufacturers to distribute generic versions of Shionogi’s oral COVID-19 antiviral ensitrelvir across low- and middle-income countries.

Coronavirus COVID-19 Intellectual Property
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Generic Drugs
UsernamePublicRestriction

Register